Parkinson's Disease Clinical Trial
Official title:
Locomotion of Parkinsonian Patient: Are There Relations Between the Long Range Autocorrelations and the Neurological Impairments, Walking Abilities and the Practice of Physical Exercise?
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The
parkinsonian gait is characterized by reducted stride length and gait speed, postural
disorders (with a high risk of falling) and a modification of stride duration variability.
This variability can be assessed by its magnitude (SD and CV) and its temporal organization
(long-range autocorrelations). Healthy human gait presents with an interdependency between
consecutive cycles that can span over hundreds of strides (long-range autocorrelations).
Numerous observations plead for a relation between long-range autocorrelations and
functional abilities of the system. Complementary to drugs, rehabilitation becomes an
important way to treat PD.
The aim of our study is to assess by a controlled, randomized, single blinded clinical
study, the effect of physical exercise on stride duration variability, neurological
impairments and walking abilities of parkinsonian patients.
Physical exercise program will include 30 sessions spread over 15 weeks following the
guidelines. Long-range correlations analysis, including the study of Hurst and α exponents,
will be performed on a minimum of 512 consecutive cycles. Finally, the functional assessment
of the parkinsonian patient will be done according to International Classification of
Functioning Disability and Health (ICF).
BACKGROUND
One of the most common features of human movement is its variability across multiple
repetition of the same rhythmic task (1). In humans, many periodic signals, such as gait,
heartbeat, respiratory and neuronal activities are characterized by their temporal
complexity, fluctuating in a complex manner over time. Although fluctuations between cycles
could appear to vary randomly, without apparent correlations between cycles, healthy systems
possess the memory of preceding values of the series displaying a complex temporal
structure.
In order to assess variability in physiological time series, several mathematical methods
can be used. On one hand, classical mathematical methods, usually applied on shorter time
series (tens of data points), quantify the fluctuation magnitude in a set of values
independently of their order in the distribution, by computing the standard deviation (SD)
and the coefficient of variation (CV). On the other hand, more complex mathematical methods,
applied on longer time series (≥512 cycles), can be used to assess the fluctuation dynamics
over time (3). These latter methods have demonstrated that variability of numerous
physiological signals (cardiac and respiratory rhythm or locomotor activities e.g.) exhibit
long-range autocorrelations, whereby the statistical inter-dependency between cycles spans
of a very large number of cycles (14).
This temporal organization of variability is thus an intrinsic property within numerous
biological systems. Moreover, it could provide insight into the neurophysiological
organization and into the regulation of these systems (32). Recent studies claimed that
these fluctuations, included in an optimal range, would represent the underlying physiologic
capability to make flexible adaptations to everyday stresses placed on the human body (32).
Therefore, the presence of such temporal dynamics is thought to be a critical marker of
health and their breakdown as an index of pathological condition (18, 25, 32). In human
heart rate for instance, deviations from an optimum of variability in either the direction
of randomness (atrial fibrillation e.g.) or the over-regularity (congestive heart failure
e.g.) indicate the loss of the adaptive capabilities of the system (9, 32).
Alongside, some central nervous system diseases influence the variability, especially, of
gait. Indeed, neurodegenerative disorders such as Parkinson and Huntington diseases are
characterized, among others, by a modification of walking variability (observed by a
breakdown of long-range autocorrelations) and a high risk of falling. Although the origin of
long-range autocorrelation remains unknown, their breakdown in such diseases suggests a
central control mechanism (8, 11, 13, 16, 17, 36).
RESEARCH PROJECT
Affecting about 1% of the population over the age of 60, Parkinson's disease (PD) is one of
the most common neurodegenerative disorders. PD is progressive in nature, and so patients
face increased difficulties with activities of daily living and various aspects of mobility
such as gait, transfers, balance, and posture. Ultimately, this leads to decreased
independence, inactivity, and social isolation, resulting in reduced quality of life.
Consequently, the improvement of locomotion is one of the most important aims of the
management of PD.
The management of PD has traditionally centered on drug therapy, with levodopa viewed as the
"gold standard" treatment. However, even with optimal medical management, parkinsonian
patients experience deterioration in body function, daily activities and participation. For
this reason, support has been increasing for the inclusion of rehabilitation therapies as an
adjuvant to pharmacological and neurosurgical treatment. Indeed, regular physical activity
slows down the progression and decrease the fall risk. Moreover, exercise has demonstrated
its effectiveness for both preservation of functional abilities and prevention of
complications (cardiovascular, osteoporosis,…).
Until now, few studies have included the analysis of variability in the functional
assessment of patients presenting a neurological disease, such as PD. Yet, walking disorders
and falls represent not only an important cost for the society but also a sizeable
individual risk of morbi/mortality. An appropriate rehabilitation program should allow for
reduction at once the risks and costs resulting from these disorders. The investigator
hypothesize that the analysis of walking variability could be useful as clinical tool in the
assessment of fall risk and as assessment tool of the therapeutic effectiveness (medication
and/or physical exercise) in PD. Therefore, the aims of this study are (1) to assess the
influence of physical exercise on human walking variability and (2) to study its potential
correlations with walking abilities and neurological impairments of parkinsonian patients.
Patients
The investigators will recruit 50 patients with idiopathic Parkinson's disease from the
department of Neurology of Cliniques universitaires Saint-Luc (Brussels, Belgium) The study
is approved by the ethics committee. All patients will give informed written consent to the
study. Eligibility criteria are: diagnosis idiopathic Parkinson (according to the Brain Bank
criteria of the United Kingdom Parkinson's Disease Society), disease severity (according to
modified Hoehn & Yahr stages I to IV), absence of dementia (Minimal Mini Mental State
Examination score of 24 or higher), stable drug usage in the last 4 weeks and adequate
vision and hearing, achieved using corrective lenses and/or hearing aid if required.
Patients will be excluded if they have severe co-morbidity, other neurological problems,
acute medical problems (e.g. MI, diabetes) and joint problems affecting mobility, and
unpredictable "Off"-periods (score >2, MDS-UPDRS item 4.5).
Procedure
The present study is a controlled, randomized, single blinded clinical study with a
crossover design. The control group will not change its usual physical activity whereas the
intervention group will benefit from the physical exercise program. This latter will include
30 sessions of circuit-group training of 60 min (twice a week) spread over 15 weeks. Then,
the two groups will be crossed. According to the recent guidelines, the program will include
a specific work on balance, posture, gait, fitness, dual tasks and stretching. All sessions
will be performed at an adequate intensity (i.e. 60-80% of predicted maximal heart rate). At
least 512 cycles will be recorded (at a high sampling rate (512 Hz)) on a treadmill at a
self-selected comfortable speed using a unidimensional accelerometer taped on the right
lateral malleolus.
Functional assessment based on the 3 domains of the International Classification of
Functioning, Disability and Health (ICF)
Patients will be assessed before intervention (T0) and at 15 (T1), 30 (T2), 45 (T3) and 60
weeks (T4) among the 3 ICF domains:
Impairments will assessed by MDS-UPDRS, an instrumented gait analysis (kinematic, kinetic,
electromyographic and energetic) (18), the 6 minute walk distance, the 10 meter walk test,
the ABC-Scale and the BESTest (including the Functional Reach Test, the Push & Release and
the Get Up & Go test).
Activities, participation and quality of life will be evaluated the Impact on Participation
and Autonomy Questionnaire (IPAQ) and a fall diary.
Walking variability analysis
Revolution time variability will be appreciated by classical and complex mathematical
methods. Classical mathematical methods (standard deviation, coefficient of variation) allow
for evaluating the fluctuation magnitude, while complex mathematical methods (long-range
autocorrelations) assess the dynamics of fluctuations over time (3).
The presence of long-range autocorrelations will be evaluated using the integrated approach
proposed by Rangarajan and Ding and validated by Crevecoeur et al. in the context of
physiological time series. These methods are described in greater details elsewhere.
Briefly, the Hurst exponent (H) will be calculated using the rescaled range analysis and the
α exponent will be evaluated using the power spectral density of the time series. For each
time series, both methods will be applied to sequences of 512 consecutive gait strides.
In theory, the exponents H and α are asymptotically related by the relation H. Hence, the
integrated approach consists of separately computing H and α, and verifying that these two
parameters are consistent through the equation d=H-(1+α)/2=0. A value of d ≤ 0.10 is
considered acceptable since the asymptotic parameters are evaluated on finite time series.
In summary, the following three conditions must be satisfied to conclude for the presence of
long-range autocorrelations :
H > 0.5; α is significantly different from 0 and lower than 1; and d ≤ 0.10
When inconsistencies appear between H and α, the investigators will use the randomly
shuffled surrogate data test to reject the null hypothesis that the series under
investigation has no temporal structure (i.e. uncorrelated random process).
PERSPECTIVES
By studying the influence of physical exercise on human walking variability and its
potential correlations with walking abilities and neurological impairments of parkinsonian
patients, the investigators hope to demonstrate that the analysis of walking variability
could be use as a clinical tool in the assessment of fall risk and as an assessment tool of
the therapeutic effectiveness (medication and/or physical exercise) in PD.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 |